By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intrexon Corporation 

20374 Seneca Meadows Parkway

Germantown  Maryland  20876  U.S.A.
Phone: 301-556-9900 Fax: 301-556-9901


Through the engineering of biology, Intrexon is helping to address some of the world’s most pressing challenges and is working with industry and government leaders to realize a better, healthier planet. Today our platform is delivering new therapies in health, supplying unique solutions to address global energy demand, developing unparalleled features and productivity advancements in food, creating innovative applications for consumers, and helping to restore and protect the environment.

To execute on its mission, Intrexon has integrated a suite of technologies and expertise across a number of cellular systems to drive development and commercialization of bio-based solutions. Our solutions include: Friendly™ Aedes mosquitoes genetically engineered to suppress the invasive Aedes aegypti mosquito; Arctic® apples that will not brown when bitten, sliced, or bruised; a clinically validated transcriptional gene switch to precisely control production of biotherapeutics; bovine reproductive technologies driving genetic gain for the dairy and beef industries; genetically engineered miniature swine models to provide better predictive efficacy in evaluation of new medicines; and our AquAdvantage® salmon bringing productivity benefits to the aquaculture industry through our majority-owned subsidiary AquaBounty. Intrexon’s cutting-edge platforms have broad applicability, thus opening the door to the considerable potential of engineered biology.

Intrexon and our collaborators are building solutions to challenging issues across fields as diverse as medicine, fuel, agriculture, nutrition, personal care, chemicals, and manufacturing, forging a sustainable path forward for current and future generations. We call our approach Better DNA® and invite you to discover more at or follow us on Twitter at @Intrexon, on Facebook and LinkedIn.

Key Statistics

Ownership: Public

Web Site: Intrexon
Symbol: XON

Company News
Where Billionaire-Led Intrexon (XON) Could Be in 10 Years 4/19/2017 6:45:16 AM
Shakeup at Intrexon (XON) as a Subsidiary is Created and an Ex-Pfizer (PFE) Exec Exits in Reorg 3/13/2017 5:45:12 AM
Andy Bass To Lead Biological & Popular Culture, Intrexon (XON)'s Consumer Sector 3/6/2017 10:41:47 AM
Intrexon (XON) Announces Fourth Quarter And Full Year 2016 Financial Results 3/2/2017 9:34:35 AM
Intrexon (XON) To Announce Fourth Quarter And Full Year 2016 Financial Results On March 1st 2/22/2017 11:12:29 AM
Lt. Gen. (Ret.) Thomas P. Bostick, Head Of Intrexon (XON)'s Environment Sector, Elected To National Academy Of Engineering 2/13/2017 8:29:11 AM
Intrexon (XON) Release: Company To Acquire GenVec (GNVC) To Expand Industry-Leading Gene Delivery Platform 1/24/2017 8:27:15 AM
Intrexon (XON) Release: Company Announces "When-Issued" Trading Of AquaBounty Technologies In Connection With Special Stock Dividend Of Shares 1/12/2017 8:10:28 AM
ZIOPHARM Oncology (ZIOP) Release: Biopharma And Intrexon (XON) Announce Cooperative Research And Development Agreement With The NCI Utilizing Sleeping Beauty System To Generate T Cells Targeting Neoantigens 1/10/2017 10:42:37 AM
Intrexon (XON) Announces A Special Stock Dividend Of Shares Of AquaBounty Technologies 12/29/2016 7:19:31 AM